Navigation Links
Clarient to Commercialize Novel Breast Cancer Profile
Date:1/9/2008

t our strong cancer-focused brand, support and loyalty among community pathologists and our unique, Internet-based PATHSiTE(TM) delivery system will drive market acceptance for this exciting test."

The new breast cancer profile has undergone rigorous validation. The results to date show excellent accuracy and substantial out-performance of standard treatment guidelines. As preparations are made for full market launch in 2008, the companies will continue to generate clinical data designed to further expand the established indications and to comply with future regulatory requirements. The companies believe that Clarient's Insight Dx Breast Cancer Profile fits the description of a lab-developed test according to the current regulatory guidelines. Should the FDA adopt proposed guidance to regulate certain lab-developed tests, the companies intend to submit the required documentation for clearance within the timeframe provided.

"Clarient currently performs approximately 20 percent of all breast cancer prognostic work-ups in the U.S.," Andrews continued. "We are extremely proud of the brand we have developed in such a short period in the area of breast cancer, and the availability of this high-value test could improve patient care and decrease the economic burden on the healthcare system."

About Prediction Sciences

Based in La Jolla, California, Prediction Sciences develops high-value molecular diagnostics and assays for disease detection, prognosis, and treatment outcome prediction under their trademarked brand names, RapidResponse(TM) and GeneRx(TM). Prediction Sciences has a deep diagnostics pipeline, with lead candidates that address critical unmet clinical needs in oncology and stroke. Prediction Sciences is committed to improving the safety and efficacy of disease treatments, and their diagnostic tests are making personalized medicine a reality. http://www.predict.net

About Clarien
'/>"/>

SOURCE Clarient
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Clarient CEO Ron Andrews to Participate in OneMedPlace Emerging Healthcare Technologies Finance Forum
2. Alba Therapeutics Corporation and Shire plc Enter Into $325 Million ex-US, ex-Japan Licensing Agreement to Develop and Commercialize AT-1001
3. Neurocrine Biosciences and Dainippon Sumitomo Pharma (DSP) Announce Agreement to Develop and Commercialize Indiplon in Japan
4. Affymax(R) and Takeda Recognized for Innovative Global Agreement to Develop and Commercialize Hematide(TM) for Anemia
5. Rib-X Pharmaceuticals Initiates Two Phase 2 Studies for Novel Antibiotic Compound RX-1741
6. New Drug Application for Tolvaptan, Otsukas Investigational Novel Oral Treatment for Worsening Heart Failure and Hyponatremia, Accepted by the U.S. Food and Drug Administration
7. Human Genome Sciences and Aegera Therapeutics Announce Licensing and Collaboration Agreement on Novel Anti-Cancer Drugs
8. Bystolic(TM), a Novel Beta Blocker, is Now Approved by the FDA for the Treatment of Hypertension
9. Oxford Genome Sciences and Amgen to Jointly Discover Novel Therapeutic Antibodies in Cancer
10. First European Patient Treated in CABERNET Trial With Novel Treatment for Wet AMD
11. DOE JGI plumbs termite guts to yield novel enzymes for better biofuel production

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...Nov. 25 Reportlinker.com announces... its catalogue: ,, Brazil Bioethanol Market An...portlinker.com/p0165503/Brazil-Bioethanol-Market-A...ioethanol Market Analysis and Forecasts to 2013 ,...nalysis and forecasts of the global bioethanol mar...
(Date:11/24/2009)...e New York investment bank KTA Capital,s client Ne...U$6.7 mil convertible note private placement with ...nt was arranged by KTA Capital as Neuren,s exclusi... New York (PRWEB) November 23, 2009 -- The... LLC ("KTA Capital") has announced that ...
(Date:11/24/2009)...ealth care employment grew by 29,000 jobs in Octo...nsistent growth during the U.S. recession. However...e, and health systems are coming closer to having ... administrators. , (Vocus...inued growing in October despite the shedding of j...
(Date:11/24/2009)... Blue Marble Energy Corp. announce...elopment Authority (OPDA) were recently awarded $2...Revitalization Board (CERB) in a private/public pa... biochemical biorefinery in Lincoln County, WA. ...e development of our biorefinery and bring over 70...
Breaking Biology Technology:Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 2Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 3Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 4Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 5Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 6Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 7Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 8Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 9Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 10KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2
...ovo, Inc.,(Nasdaq: BNVI ) today announced results... The company did not report any revenue for the t...otal operating expenses for the three and nine mon...d $13.7 million, respectively, compared to,$3.6 mi... period in 2007.,This reflects the increase in cos...
...tion scientist interactions and provides ...ORD, Mass., Nov. 3 Waters Corporation,(NYSE: WAT...ine community,designed to support the success of n...Created especially for Waters(R) ACQUITY UltraPerf...rship in this new online,community has already rea...
...(Amex: NBS ),which is pioneering the pre-disease ...ult stem cells for future medical need, announced ...rporation, whose wholly-owned,subsidiary, Beijing ..., has,a series of contracts with Shandong New Medi...and Western Medicine LLC that establish control ov...
Other Biology Technology:Bionovo Reports Third Quarter 2008 Financial Results 2Bionovo Reports Third Quarter 2008 Financial Results 3Bionovo Reports Third Quarter 2008 Financial Results 4Bionovo Reports Third Quarter 2008 Financial Results 5Bionovo Reports Third Quarter 2008 Financial Results 6Bionovo Reports Third Quarter 2008 Financial Results 7Waters New ACQUITY UPLC Online Community Attracts More Than 1,200 Members in First Month 2NeoStem, Inc. to Enter the Regenerative Medicine Market in Asia 2NeoStem, Inc. to Enter the Regenerative Medicine Market in Asia 3NeoStem, Inc. to Enter the Regenerative Medicine Market in Asia 4
(Date:11/24/2009)...24, 2009) -- The Wildlife Conservation Society (WC...t remaining population of Siberian tigers has like...f poaching and habitat loss. , WCS s...of what needs to be done to protect remaining popu... The report was released by the Siberian Tiger M...
(Date:11/23/2009)...ong evidence that the "synergistic" effect of earl...llution and indoor endotoxin causes more harm to d...ne. , Environmental health scientists at the U...ave shown that children exposed to both high level...n during early life are six times more likely to e...
(Date:11/23/2009)...ticipants gathered this week for the seventh annua...rence. This year,s topic, "Synthetic Biology," bro...esearchers to explore the engineering, scientific,...of synthetic biology. , Bonnie L. Bassler, profe...and this year,s conference chair, challenged the a...
Breaking Biology News(10 mins):Report shows dramatic decline in Siberian tigers 2Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2Synthetic biology offers new opportunities for interdisciplinary collaboration 2Get Ready for Gruesome Cigarette Warnings 55508 1Get Ready for Gruesome Cigarette Warnings 55508 2Get Ready for Gruesome Cigarette Warnings 55508 3Hisamitsu Pharmaceutical Announces Expiration of Subsequent Offering Period and Completion of Tender Offer for Outstanding Shares of Noven Pharmaceuti 55506 1Hisamitsu Pharmaceutical Announces Expiration of Subsequent Offering Period and Completion of Tender Offer for Outstanding Shares of Noven Pharmaceuti 55506 2Sandata Selected by Volunteer State Health Plan to Manage TennCare Choices 55504 1Sandata Selected by Volunteer State Health Plan to Manage TennCare Choices 55504 2
...y 3, 2009 Ben W. Strowbridge, Ph.D, associate prof...nd Yuan Gao, a Ph.D. student in the neurosciences ...of Medicine, are the first to discover a form of s...the brain that processes the sense of smell. , Th...atory inputs to granule cells in the rat olfactory...
... several studies evaluating new techniques for ear...g presented at the first European Multidisciplinar...o, Switzerland (1-3 May 2009). , "Lung cancer is ...lso in Europe. One of the reasons for this is that... occur only late in the course of the disease," sa...
...r daily cup of coffee and subsequently get a pound...of coffee and other caffeinated products, caffeine...fatigue, feeling less alert, less energetic and ex...rom the University of Vermont College of Medicine ...estigate the biological mechanisms of caffeine wit...
Other Biology News:Neuroscientists discover long-term potentiation in the olfactory bulb 2Neuroscientists discover long-term potentiation in the olfactory bulb 3Early detection of lung cancer: New data presented at multidisciplinary meeting 2Your brain on -- and off -- caffeine 2
...e Inhibitors have broad spectrum RNase inhibitory ... RNases of the neutral type (1). The 50kDa protein...ding to RNases in a 1:1 ratio. The Ki value for th...e (e.g., RNase A) is approximately 1014M (24). Pro...
... ,The GC-RICH PCR System, a blend of Taq DNA Po...ough templates that are difficult or impossible to...f polymerases. The enhanced processivity of the bl...bine to deliver superior performance especially f...
Anti-Taq Monoclonal Antibody, Unconjugated from eEnzyme LLC
Rabbit Anti-B-FABP (FL-132) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Biology Products: